Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: Inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli

188Citations
Citations of this article
94Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Using a continuous fluorescence-based enzyme assay, we have characterized the antibacterial agents tunicamycin and liposidomycin B as inhibitors of solubilized Escherichia coli phospho-N-acetylmuramyl- pentapeptide translocase. Tunicamycin exhibited reversible inhibition (K(i) = 0.55 ± 0.1 μM) which was noncompetitive with respect to the lipid acceptor substrate and competitive with respect to the fluorescent substrate analog, dansyl-UDPMurNAc-pentapeptide. Liposidomycin B exhibited slow-binding inhibition (K(i) = 80 ± 15 nM) which was competitive with respect to the lipid acceptor substrate and noncompetitive with respect to dansyl-UDPMurNAc- pentapeptide. These results provide insight into the molecular mechanisms of action of these two classes of nucleoside antibiotics.

Cite

CITATION STYLE

APA

Brandish, P. E., Kimura, K. I., Inukai, M., Southgate, R., Lonsdale, J. T., & Bugg, T. D. H. (1996). Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: Inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli. Antimicrobial Agents and Chemotherapy, 40(7), 1640–1644. https://doi.org/10.1128/aac.40.7.1640

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free